收到告知书及处理决定后，公司进行了全面自查，发现公司时任董事、全资子公司深圳嘉力达节能科技 有限公司（简称"嘉力达"）董事长李海建在2019年到2020年期间存在资金占用情况。但对于李海建的资 金占用规模及具体实施细节，公司并未披露。 据悉，2018年启迪设计收购嘉力达，作为嘉力达董事长的李海建因此进入上市公司董事会。李海建等相 关主体作为业绩补偿义务人曾承诺，嘉力达2017-2021年扣非净利润合计不低于2.32亿元，但后续未能 兑现承诺，差额约2421万元。启迪设计称，公司高度重视业绩承诺补偿的追讨工作，全力维护公司及全 体股东利益，并依据相关规则及时履行信息披露义务。 智通财经记者注意到，启迪设计2022年报、2023年报均被深圳证券交易所问询。 登录新浪财经APP 搜索【信披】查看更多考评等级 面对每天上千份上市公司公告该看哪些？重大事项公告动辄几十页几百页重点是啥？公告里 一堆专业术语不知道算利好还是利空？请看智通财经公司新闻部《速读公告》栏目，我们派 驻全国的记者们将于公告当晚为您带来准确、快速、专业的解读。 智通财经12月31日讯（记者 罗祎辰）因涉嫌信息披露违法违规，启迪设计（300500.S ...

铂力特于7月8日晚间公告，公司2025年4月披露的2024年年报和2025年一季报存在多处错误，违反了《上市公司信息披露管理办法》第三条第一款的规 定，陕西证监局决定对公司、董事长兼总经理薛蕾、财务总监梁可晶采取出具警示函的行政监管措施。 在此之前，铂力特于6月10日晚间回复此前上交所对公司下发的2024年报告的信息披露监管问询函，就公司关于收入变动合理性、应收款项变动、在建工 程及预付款项等进行了说明。 回复公告披露，铂力特对2023年年报、2024年一季报、半年报、三季报以及2024年业绩快报进行会计差错更正，主要涉及收入、成本、利润、应收账款、 存货等报表项目。上交所要求公司说明本次对各定期报告及业绩快报进行会计差错更正的具体情况，同时说明相关报告期是否还存在其他类似情形。铂力 特在回复函中表示，出现相关会计差错的主要原因是公司财务人员对会计准则的理解不到位，对合同识别错误，以及收入确认的依据存在瑕疵，导致部分 收入确认出现差错。 资料显示，铂力特主营业务是金属3D打印设备及产品的研发、生产和销售，主要产品是选择性激光熔化成形、激光立体成形、电弧增材制造等系列金属 3D打印设备等。 12月31日晚，铂力 ...

Core Viewpoint - The company, *ST Panda, is facing significant financial challenges, including a major revision of its profit forecast for 2024, which now indicates a substantial loss instead of a profit, raising concerns about its financial stability and compliance with regulatory standards [4][9]. Financial Performance - The initial profit forecast for 2024 was estimated to be between 30 million to 45 million yuan, indicating a potential profit compared to the previous year [4][9]. - Following a self-examination, the company announced a credit impairment loss of 580 million yuan on other receivables and current assets, leading to a revised profit forecast indicating a net loss of between 460 million to 480 million yuan for 2024 [4][9]. - The auditing firm, Lianda CPA, issued an audit report with no opinion due to significant fluctuations in profits and large losses over the past three years, establishing a materiality threshold of 13 million yuan for the consolidated financial statements [4][9]. Regulatory Issues - On December 29, 2025, the company received a notice from the China Securities Regulatory Commission regarding an investigation into alleged violations of information disclosure laws [2][7]. - There are two potential compensation periods for investors: one for those who bought shares between January 23, 2025, and April 27, 2025, and another for those who purchased shares before December 29, 2025, and sold or continued to hold them after December 30, 2025 [5][10].

Core Viewpoint - Panda Financial Holdings Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following a series of financial irregularities and management issues [1][4]. Financial Irregularities - The company's 2024 financial statements received an audit report that could not express an opinion, and internal controls have been given negative opinions for five consecutive years, highlighting issues such as unauthorized use of seals and chaotic small loan operations [4]. - In 2024, the company provided a pledge guarantee for 300 million yuan of term deposits without board approval, later replacing the funds and fully recognizing impairment losses [4]. - An additional 176 million yuan was reported to have flowed out under the guise of procurement and acquisition payments, with unverified destinations [4]. Management Issues - The actual controller, Zhao Weiping, was arrested in 2022 for illegal public deposit absorption, leading to the freezing of all his shares [4]. - The company's 2024 performance forecast shifted from profit to loss, indicating serious discrepancies in the earnings forecast [4]. Investor Compensation - Affected investors who purchased shares between December 2, 2024, and April 27, 2025, and held them can voluntarily register for compensation through the "Sina Investor Rights Protection Platform," regardless of whether they sold shares after April 28, 2025 [2][5].

Core Viewpoint - ST HuLuWa is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, leading to a significant drop in stock price and market capitalization [1][2]. Group 1: Investigation Background - This is not the first time ST HuLuWa has faced issues with information disclosure, having previously received criticism for inaccurate financial data in multiple reports [2]. - The company's chairman, Liu Jingping, has been criticized for failing to timely disclose the 2024 annual performance forecast, indicating serious internal control and financial compliance issues [2]. Group 2: Financial Performance Decline - ST HuLuWa's financial performance has deteriorated sharply since 2024, with total revenue of 1.414 billion yuan, a year-on-year decrease of 21.26%, and a net loss of 274 million yuan, a decline of over 2600% [3]. - In the first three quarters of 2025, the company reported revenue of 683 million yuan, down 33.88%, and a net loss of 11.21 million yuan [3]. - Due to internal control issues, the company received an audit report that could not express an opinion, leading to its stock being classified as a "ST stock" from April 30, 2025 [3]. Group 3: Shareholder Equity Freeze - The controlling shareholder, Hainan HuLuWa Investment Development Co., Ltd., has had 23.9 million shares frozen, representing 5.97% of the total share capital, due to a triggered early redemption clause [4]. - The freezing of shares is often seen as a signal of governance and liquidity risks, which could lead to forced share reductions or changes in control if debt issues are not resolved [4]. - ST HuLuWa is currently facing compounded pressures from regulatory investigations, operational losses, and shareholder equity freezes, raising concerns about its future stability and market confidence [4].

公司于2025年12月12日收到中国证监会湖北监管局下发的《行政处罚事先告知书》（鄂处罚字〔2025〕 8号），具体内容详见公司于2025年12月13日披露的《人福医药集团股份公司关于收到中国证券监督管 理委员会湖北监管局〈行政处罚事先告知书〉的公告》（公告编号：临2025-128号）。 公司及相关责任人于2025年12月29日收到中国证监会湖北监管局出具的《行政处罚决定书》（〔2025〕 10号），现将相关情况公告如下： 一、《行政处罚决定书》主要内容 当事人：人福医药集团股份公司（以下简称人福医药），住所：湖北省武汉市东湖高新区。 武汉当代科技产业集团股份有限公司（以下简称当代集团），住所：湖北省武汉市东湖新技术开发区。 艾路明，男，195×年5月出生，时任当代集团董事，住址：湖北省武汉市洪山区。 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 人福医药集团股份公司（以下简称"公司"）及原控股股东武汉当代科技产业集团股份有限公司（以下简 称"当代科技"）于2024年10月2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 一、正式处罚落地 12月29日，ST人福（维权）公告，公司及控股股东收到湖北监管局的《行政处罚事先告知书》，公司 及相关主体涉嫌多项信息披露违法违规行为，涉及非经营性资金占用、关联交易未披露、年报虚假记载 等多方面问题。 监管对人福医药公司处以850万元罚款；对原控股股东当代集团处以900万元罚款；相关责任人同步领 罚。 因此引发的投资者索赔事宜，上海沪紫律师事务所刘鹏律师团队代理的案件已按顺序陆续递交立案，还 在征集受损投资者中。 二、存在巨额资金占用 湖北证监局调查认定的违法事实，揭示了人福医药及其原控股股东"当代集团"在数年间的一系列违规操 作。 2020年至2022年期间，ST人福及当代集团存在多项违法事实：一是非经营性资金占用累计127.85亿元未 及时披露，且2020年年度报告遗漏该信息；二是2022年3月下属子公司与关联方16.45亿元物业资产交易 未及时披露，且未载入当年年报；三是2020年至2022年半年度多份财报存在虚假记载，累计虚增归母净 利润超3亿元；四是当代集团隐瞒关联关系，导致公司1亿元股权收购交易未按规定披露关联信息。 监管部门的 ...

Core Viewpoint - *ST Panda (600599.SH) experienced a significant drop today, closing at 10.45 yuan, following a series of five trading limit increases over the past eight trading days, with sell orders exceeding 130,000 lots [1] Group 1: Regulatory Actions - The company received a "Notice of Investigation" from the China Securities Regulatory Commission (CSRC) on December 29, 2025, due to suspected violations of information disclosure laws [1] - The CSRC has decided to initiate an investigation against the company based on the Securities Law of the People's Republic of China and the Administrative Penalty Law [1] Group 2: Company Operations - Despite the ongoing investigation, the company's production and operational activities are reported to be functioning normally [1] - The company will actively cooperate with the CSRC during the investigation and will adhere to relevant laws and regulatory requirements for timely information disclosure [1]

Group 1 - The core issue involves investor compensation claims against Beiqing Song (688793) due to alleged false statements leading to legal actions initiated by investors [1] - On December 25, 2025, Beiqing Song announced it received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into information disclosure violations by the company and its actual controller, Ma Xuejun [1] - Investors who purchased Beiqing Song shares on December 26, 2025, and held or sold them afterward are eligible to prepare for compensation claims [1] Group 2 - The law firm representing investors, led by attorney Xu Feng, has also initiated compensation claims for investors of Peng Bo (600804), with some investors receiving a settlement through mediation [1] - Peng Bo's annual reports from 2012 to 2022 contained false records, including a profit inflation of 42,456,137.95 yuan in 2012, which accounted for 17.43% of that year's total profit [1] - Peng Bo's annual reports from 2017 to 2019 also showed inflated assets, with the 2016 report inflating assets and profits by 162,000,000 yuan, representing 17.48% of that year's total profit [1] Group 3 - Peng Bo's net assets were reduced by 196,000,000 yuan annually from 2020 to 2022, which constituted 21.77%, 14.27%, and 18.51% of the net assets at the end of each respective year [2] - The company issued bonds "17 Peng Bo Bond" and "18 Peng Bo Bond," with the latter being extended to 2024, involving financial statements from 2014 to 2017 [2] - Investors who bought Peng Bo shares between April 12, 2013, and July 18, 2023, and held or sold them afterward can also initiate compensation claims [2] Group 4 - Peng Bo failed to disclose related party transactions as required [3] - The company also did not disclose significant contracts as mandated [3]

Group 1 - The core issue involves investor compensation claims against Beiqing Song (688793) due to alleged false statements leading to violations of information disclosure laws [1][7] - The China Securities Regulatory Commission (CSRC) issued a notice on December 25, 2025, indicating that Beiqing Song and its actual controller, Ma Xuejun, are under investigation for information disclosure violations [1][7] - Investors who purchased Beiqing Song shares on December 26, 2025, or later are eligible to prepare for compensation claims [8] Group 2 - The Peng Bo (600804) investor compensation case has received a court mediation document, indicating that investors will receive compensation [8] - A first-instance judgment has been delivered in the Peng Bo investor compensation case, resulting in a certain percentage of victory for the investors [2][8] - The law firm continues to accept compensation claims from other investors related to Peng Bo [2][8] Group 3 - Peng Bo has been penalized by the CSRC for failing to disclose related party transactions and significant contracts as required [3][9][10] - From 2012 to 2022, Peng Bo's annual reports contained false records, including a profit inflation of 42,456,137.95 yuan in 2012, which accounted for 17.43% of that year's total profit [5][11] - The company inflated assets in annual reports from 2012 to 2015 and reported inflated profits of 162,000,000 yuan in 2016, which represented 17.48% of that year's total profit [5][11] - From 2020 to 2022, Peng Bo's annual reports showed a reduction in net assets of 196,000,000 yuan, which accounted for 21.77%, 14.27%, and 18.51% of the net assets at the end of 2020, 2021, and 2022, respectively [5][11] Group 4 - Investors who bought Peng Bo shares between April 12, 2013, and July 18, 2023, and held or sold them after July 18, 2023, are eligible to initiate compensation claims [6][12]